Effectiveness of Simvastatin Versus Gemfibrozil for Primary Prevention of Cardiovascular Events: A Retrospective Cohort Study of 223,699 Primary Care Patients.
Clin Drug Investig
; 42(11): 987-997, 2022 Nov.
Article
de En
| MEDLINE
| ID: mdl-36239913
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Gemfibrozil
/
Maladie coronarienne
Type d'étude:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Risk_factors_studies
Limites:
Female
/
Humans
/
Male
Langue:
En
Journal:
Clin Drug Investig
Sujet du journal:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Année:
2022
Type de document:
Article
Pays d'affiliation:
Chine
Pays de publication:
Nouvelle-Zélande